CBS19 News25m
Virginia Residents Are Using GLP-1s at a Below Average Rate
Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...
New study suggests weight loss drugs like Ozempic could help with knee pain. Here’s why there may be a link
A recent study found semaglutide – the drug known as Ozempic – can improve knee pain in people with obesity and osteoarthritis.
KSJB AM1h
U.S. Obesity Market Analysis: Exploring Demographic & Geographic Disparities in GLP-1 Use
Medications such as semaglutide (branded as Ozempic and Wegovy) and tirzepatide (branded as Mounjaro and Zepbound) work by ...
The Manhattan Mercury2h
Kansas Residents Are Using GLP-1s at an Above Average Rate
Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...
Southern Minn2h
Iowa Has the 9th Highest Rate of GLP-1 Use in the Country
Medications such as semaglutide (branded as Ozempic and Wegovy) and tirzepatide (branded as Mounjaro and Zepbound) work by ...
Southern Minn2h
Minnesota Has the 13th Lowest Rate of GLP-1 Use in the Country
Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...
Hastings Tribune2h
Nebraska Residents Are Using GLP-1s at a Slightly Above Average Rate
Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...
The Mountain Press2h
Tennessee Residents Are Using GLP-1s at the 13th Highest Rate in the Country
Medications such as semaglutide (branded as Ozempic and Wegovy) and tirzepatide (branded as Mounjaro and Zepbound) work by ...
ConsumerAffairs2h
Diabetes Cure
If you said diabetes, you're right -- a new study finds diabetes costs $101 billion annually in diagnosis and treatment and ...